Form 8-K - Current report:
SEC Accession No. 0001193125-12-500248
Filing Date
2012-12-12
Accepted
2012-12-12 17:04:49
Documents
3
Period of Report
2012-12-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d450150d8k.htm 8-K 25826
2 PRESS RELEASE d450150dex991.htm EX-99.1 11433
3 GRAPHIC g450150ex99_1pg01.jpg GRAPHIC 18580
  Complete submission text file 0001193125-12-500248.txt   64734
Mailing Address FIRST FLOOR, BLOCK 3, THE OVAL, SHELBOURNE ROAD, BALLSBRIDGE DUBLIN L2 00000
Business Address FIRST FLOOR, BLOCK 3, THE OVAL, SHELBOURNE ROAD, BALLSBRIDGE DUBLIN L2 00000 353 1 6699 020
AMARIN CORP PLC\UK (Filer) CIK: 0000897448 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 333-176897 | Film No.: 121259812
SIC: 2834 Pharmaceutical Preparations